rawfin.tv
Two Seas Capital Reports 9.4% Stake in Arbutus Biopharma
MarketsstocksAI Generated

Two Seas Capital Reports 9.4% Stake in Arbutus Biopharma

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Two Seas Capital LP, along with its affiliates, has reported a beneficial ownership of 18,557,543 common shares in Arbutus Biopharma. This represents a 9.4% stake in the company.

ABUSOwnership StakeInstitutional InvestorsBiotechnology SectorSEC Filings

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks